A @School_Pharmacy study, published in the British Journal of Clinical Pharmacology, investigated the impact of statin-related adverse drug reactions on treatment pattern changes and patients’ outcomes in a primary care setting. https://t.co/Y7D8jbpBrg
Happy to see our paper published at BJCP journal. The study led by @widyainsani included more than 1,5 million statin users and investigated CVD events and all-cause mortality in patients with statin-related ADRs in primary care in the UK. Details👇🏼
https://t.co/nsaVMEUCyq